US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 13.930
  • +0.210+1.53%
Close Nov 29 13:00 ET
  • 14.130
  • +0.200+1.44%
Post 17:01 ET
1.40BMarket Cap-14360P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Day One Biopharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
28.45M
93.76M
+65.31M
Beat Est.
--
--
+229.56%
EPS
-0.29
0.38
+0.67
Beat Est.
+46.19%
+170.37%
+230.81%
Analyst Rating
Strong Buy

Nov 12, 2024

Day One Biopharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 32.437M--
--2024/Q4-- / 27.146M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 32.437M--
--2024/Q4-- / 27.146M--
Oct 30, 20242024/Q393.761M / 28.451M--
Jul 30, 20242024/Q28.192M / 912.220K--
--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Day One Biopharmaceuticals Earnings Reports

  • Day One Biopharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 30 16:07 ET

  • Day One Biopharmaceuticals | 8-K: Day One Reports Third Quarter 2024 Financial Results and Corporate Progress

    Oct 30 16:03 ET

  • Day One Biopharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 2 16:13 ET

  • Day One Biopharmaceuticals | 8-K: Day One Reports Second Quarter 2024 Financial Results and Corporate Progress

    Jul 30 07:40 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 12, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data